Weekly combination of oxaliplatin (OX) and irinotecan (IRI) in 5-FU resistant colorectal cancer (CRC)Albrecht Kretzschmar, Peter Reichardt, Hans‐Joachim Schmoll et al.|European Journal of Cancer|2001Cited by 4
Contents of Next Issues · ThemenvorschauPeter Thuss‐Patience, R. Sauer, Albrecht Kretzschmar et al.|Oncology Research and Treatment|2003Cited by 1